Catalyst Wire Dossier Catalyst Wire Dossier

DILANTIN-125

phenytoin · Viatris Specialty LLC
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for DILANTIN-125, covering 2009-04-23 to 2022-03-03. Get the full timeline:

Most recent: FDA Approved: DILANTIN-125 — Supplemental Application (Viatris Specialty LLC)

See pricing